Largest biotech companies by market cap: 55 companies with a combined market value of $983.42 B. Amgen Inc. (AMGN) leads at $235.98 B. Biological product and biotechnology research companies ranked by market value. Rankings update as fresh market data lands; click any company for its financial statements, charts, and SEC filing history.
| Rank | Company | Industry | Market Cap |
|---|---|---|---|
| 1 | Biological Products, (No Diagnostic Substances) | $235.98 B | |
| 2 | Biological Products, (No Diagnostic Substances) | $187.47 B | |
| 3 | Aargenx SEARGX | Biological Products, (No Diagnostic Substances) | $63.93 B |
| 4 | Biological Products, (No Diagnostic Substances) | $57.75 B | |
| 5 | Services-Commercial Physical & Biological Research | $44.69 B | |
| 6 | RRevolution Medicines, Inc.RVMD | Biological Products, (No Diagnostic Substances) | $44.65 B |
| 7 | Biological Products, (No Diagnostic Substances) | $32.60 B | |
| 8 | Biological Products, (No Diagnostic Substances) | $26.24 B | |
| 9 | Services-Commercial Physical & Biological Research | $25.32 B | |
| 10 | Services-Commercial Physical & Biological Research | $16.89 B | |
| 11 | Biological Products, (No Diagnostic Substances) | $15.65 B | |
| 12 | Biological Products, (No Diagnostic Substances) | $14.83 B | |
| 13 | Services-Commercial Physical & Biological Research | $13.90 B | |
| 14 | Biological Products, (No Diagnostic Substances) | $13.07 B | |
| 15 | IICON Public Limited CompanyICLR | Services-Commercial Physical & Biological Research | $12.59 B |
| 16 | Biological Products, (No Diagnostic Substances) | $11.34 B | |
| 17 | Biological Products, (No Diagnostic Substances) | $10.56 B | |
| 18 | AApogee Therapeutics, Inc.APGE | Biological Products, (No Diagnostic Substances) | $10.11 B |
| 19 | Biological Products, (No Diagnostic Substances) | $9.66 B | |
| 20 | Biological Products, (No Diagnostic Substances) | $9.45 B | |
| 21 | Biological Products, (No Diagnostic Substances) | $9.43 B | |
| 22 | PVaxcyte, Inc.PCVX | Biological Products, (No Diagnostic Substances) | $8.83 B |
| 23 | IImmunityBio, Inc.IBRX | Biological Products, (No Diagnostic Substances) | $8.46 B |
| 24 | IImmunovant, Inc.IMVT | Biological Products, (No Diagnostic Substances) | $8.06 B |
| 25 | Biological Products, (No Diagnostic Substances) | $7.77 B | |
| 26 | AArcellxACLX | Biological Products, (No Diagnostic Substances) | $6.73 B |
| 27 | SScholar Rock Holding CorporationSRRK | Biological Products, (No Diagnostic Substances) | $6.63 B |
| 28 | CCG Oncology, Inc.CGON | Biological Products, (No Diagnostic Substances) | $6.59 B |
| 29 | Biological Products, (No Diagnostic Substances) | $5.38 B | |
| 30 | Biological Products, (No Diagnostic Substances) | $3.92 B | |
| 31 | Biological Products, (No Diagnostic Substances) | $3.91 B | |
| 32 | TTarsus Pharmaceuticals, Inc.TARS | Biological Products, (No Diagnostic Substances) | $3.91 B |
| 33 | Biological Products, (No Diagnostic Substances) | $3.89 B | |
| 34 | Biological Products, (No Diagnostic Substances) | $3.65 B | |
| 35 | DDenali Therapeutics Inc.DNLI | Biological Products, (No Diagnostic Substances) | $3.54 B |
| 36 | Biological Products, (No Diagnostic Substances) | $3.05 B | |
| 37 | Biological Products, (No Diagnostic Substances) | $2.53 B | |
| 38 | AADMA Biologics, Inc.ADMA | Biological Products, (No Diagnostic Substances) | $2.23 B |
| 39 | KKodiak Sciences Inc.KOD | Biological Products, (No Diagnostic Substances) | $2.21 B |
| 40 | CHemab Therapeutics Holdings, Inc.COAG | Biological Products, (No Diagnostic Substances) | $2.07 B |
| 41 | Biological Products, (No Diagnostic Substances) | $2.05 B | |
| 42 | Biological Products, (No Diagnostic Substances) | $1.99 B | |
| 43 | Biological Products, (No Diagnostic Substances) | $1.93 B | |
| 44 | VVir Biotechnology, Inc.VIR | Biological Products, (No Diagnostic Substances) | $1.92 B |
| 45 | IImmunocore Holdings plcIMCR | Biological Products, (No Diagnostic Substances) | $1.84 B |
| 46 | Biological Products, (No Diagnostic Substances) | $1.68 B | |
| 47 | AAlvotechALVO | Biological Products, (No Diagnostic Substances) | $1.66 B |
| 48 | TTaysha Gene Therapies, Inc.TSHA | Biological Products, (No Diagnostic Substances) | $1.61 B |
| 49 | IInhibrx Biosciences, Inc.INBX | Biological Products, (No Diagnostic Substances) | $1.53 B |
| 50 | MMaze Therapeutics, Inc.MAZE | Biological Products, (No Diagnostic Substances) | $1.45 B |
| 51 | AAbsci CorporationABSI | Services-Commercial Physical & Biological Research | $1.38 B |
| 52 | Biological Products, (No Diagnostic Substances) | $1.36 B | |
| 53 | Biological Products, (No Diagnostic Substances) | $1.28 B | |
| 54 | Biological Products, (No Diagnostic Substances) | $1.17 B | |
| 55 | Biological Products, (No Diagnostic Substances) | $1.11 B |
Industry membership comes from each company's SEC-registered SIC classification, parsed from EDGAR submissions. Market capitalizations refresh continuously from cached market data combined with SEC-reported share counts. See the full market cap rankings or the IPO filings tracker.